Bicycle Therapeutics (BCYC) Change in Cash (2018 - 2026)

Bicycle Therapeutics has reported Change in Cash for 9 years, with the latest figure at -$68.6 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash rose 20.7% year-over-year to -$68.6 million; the trailing twelve-month figure through Mar 2026 stood at -$233.4 million (down 169.48% YoY), and the FY2025 full-year result was -$251.4 million, down 171.18% from the prior year.
• Change in Cash for Q1 2026 stood at -$68.6 million, down from -$20.2 million in the prior quarter.
• The five-year high for Change in Cash was $504.4 million in Q2 2024, with the low at -$86.5 million in Q1 2025.
• Historically, Change in Cash has averaged $7.1 million across 5 years, with a median of -$34.6 million in 2022.
• Annual changes were most pronounced in 2022 — Change in Cash tumbled 1319.67% — and 2023, when it soared 2154.88%.
• Bicycle Therapeutics' Change in Cash stood at -$22.3 million in 2022, then slumped by 104.63% to -$45.7 million in 2023, then jumped by 75.16% to -$11.3 million in 2024, then plunged by 77.72% to -$20.2 million in 2025, then tumbled by 240.51% to -$68.6 million in 2026.
• The last three Change in Cash figures came in at -$68.6 million (Q1 2026), -$20.2 million (Q4 2025), and -$73.1 million (Q3 2025), per Business Quant data.